Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 500

1.

Association of out-of-pocket costs on adherence to common neurologic medications.

Reynolds EL, Burke JF, Banerjee M, Kerber KA, Skolarus LE, Magliocco B, Esper GJ, Callaghan BC.

Neurology. 2020 Feb 19. pii: 10.1212/WNL.0000000000009039. doi: 10.1212/WNL.0000000000009039. [Epub ahead of print]

PMID:
32075894
2.

The emerging role of dyslipidemia in diabetic microvascular complications.

Savelieff MG, Callaghan BC, Feldman EL.

Curr Opin Endocrinol Diabetes Obes. 2020 Feb 18. doi: 10.1097/MED.0000000000000533. [Epub ahead of print]

PMID:
32073426
3.

Design-Based Stereology and Binary Image Histomorphometry in Nerve Assessment.

Hunter DA, Pan D, Wood MD, Snyder-Warwick AK, Moore AM, Feldman EL, Mackinnon SE, Brenner MJ.

J Neurosci Methods. 2020 Feb 15:108635. doi: 10.1016/j.jneumeth.2020.108635. [Epub ahead of print]

PMID:
32070676
4.

Risk Factors for Diabetic Peripheral Neuropathy and Cardiovascular Autonomic Neuropathy in the Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications (DCCT/EDIC) Study.

Braffett BH, Gubitosi-Klug RA, Albers JW, Feldman EL, Martin CL, White NH, Orchard TJ, Lopes-Virella M, Lachin JM, Pop-Busui R; DCCT/EDIC Study Group.

Diabetes. 2020 Feb 12. pii: db191046. doi: 10.2337/db19-1046. [Epub ahead of print]

PMID:
32051148
5.

Diabetic neuropathy: what does the future hold?

Callaghan BC, Gallagher G, Fridman V, Feldman EL.

Diabetologia. 2020 Jan 23. doi: 10.1007/s00125-020-05085-9. [Epub ahead of print] Review.

PMID:
31974731
6.

The Prevalence and Determinants of Cognitive Deficits and Traditional Diabetic Complications in the Severely Obese.

Callaghan BC, Reynolds EL, Banerjee M, Chant E, Villegas-Umana E, Gardner TW, Votruba K, Giordani B, Pop-Busui R, Pennathur S, Feldman EL.

Diabetes Care. 2020 Mar;43(3):683-690. doi: 10.2337/dc19-1642. Epub 2020 Jan 13.

PMID:
31932459
7.

Integrated lipidomic and transcriptomic analyses identify altered nerve triglycerides in mouse models of prediabetes and type 2 diabetes.

O'Brien PD, Guo K, Eid SA, Rumora AE, Hinder LM, Hayes JM, Mendelson FE, Hur J, Feldman EL.

Dis Model Mech. 2020 Jan 24;13(2). pii: dmm042101. doi: 10.1242/dmm.042101.

8.

Randomized controlled trial of a clinical decision support system for painful polyneuropathy.

Reynolds EL, Burke JF, Banerjee M, Callaghan BC.

Muscle Nerve. 2019 Dec 6. doi: 10.1002/mus.26774. [Epub ahead of print]

PMID:
31811650
9.

Human iPSC-derived astrocytes from ALS patients with mutated C9ORF72 show increased oxidative stress and neurotoxicity.

Birger A, Ben-Dor I, Ottolenghi M, Turetsky T, Gil Y, Sweetat S, Perez L, Belzer V, Casden N, Steiner D, Izrael M, Galun E, Feldman E, Behar O, Reubinoff B.

EBioMedicine. 2019 Dec;50:274-289. doi: 10.1016/j.ebiom.2019.11.026. Epub 2019 Nov 29.

10.

Metabolism, cognition, and the brain throughout life.

Sakowski SA, Cameron F, Feldman EL.

Neurobiol Dis. 2020 Feb;134:104698. doi: 10.1016/j.nbd.2019.104698. Epub 2019 Nov 28. No abstract available.

11.

Diabetic polyneuropathy and pain, prevalence, and patient characteristics: a cross-sectional questionnaire study of 5,514 patients with recently diagnosed type 2 diabetes.

Gylfadottir SS, Christensen DH, Nicolaisen SK, Andersen H, Callaghan BC, Itani M, Khan KS, Kristensen AG, Nielsen JS, Sindrup SH, Andersen NT, Jensen TS, Thomsen RW, Finnerup NB.

Pain. 2020 Mar;161(3):574-583. doi: 10.1097/j.pain.0000000000001744.

PMID:
31693539
12.

Temporal evolution of the microbiome, immune system and epigenome with disease progression in ALS mice.

Figueroa-Romero C, Guo K, Murdock BJ, Paez-Colasante X, Bassis CM, Mikhail KA, Raue KD, Evans MC, Taubman GF, McDermott AJ, O'Brien PD, Savelieff MG, Hur J, Feldman EL.

Dis Model Mech. 2019 Nov 15;13(2). pii: dmm041947. doi: 10.1242/dmm.041947.

13.

Response to Caro and Winter.

Harte SE, Clauw DJ, Feldman EL, Watson CJ.

Pain Rep. 2019 Apr 15;4(3):e734. doi: 10.1097/PR9.0000000000000734. eCollection 2019 May-Jun. No abstract available.

14.

Increased lipogenesis and impaired β-oxidation predict type 2 diabetic kidney disease progression in American Indians.

Afshinnia F, Nair V, Lin J, Rajendiran TM, Soni T, Byun J, Sharma K, Fort PE, Gardner TW, Looker HC, Nelson RG, Brosius FC, Feldman EL, Michailidis G, Kretzler M, Pennathur S.

JCI Insight. 2019 Nov 1;4(21). pii: 130317. doi: 10.1172/jci.insight.130317.

15.

Author response: Unintended consequences of Mayo paraneoplastic evaluations.

Callaghan BC, Burke JF.

Neurology. 2019 Sep 24;93(13):606-607. doi: 10.1212/WNL.0000000000008180. No abstract available.

PMID:
31551275
16.

Author response: Unintended consequences of Mayo paraneoplastic evaluations.

Callaghan BC.

Neurology. 2019 Sep 24;93(13):604. doi: 10.1212/WNL.0000000000008177. No abstract available.

PMID:
31551273
17.

The effects of insulin and insulin-like growth factor I on amyloid precursor protein phosphorylation in in vitro and in vivo models of Alzheimer's disease.

Kim B, Elzinga SE, Henn RE, McGinley LM, Feldman EL.

Neurobiol Dis. 2019 Dec;132:104541. doi: 10.1016/j.nbd.2019.104541. Epub 2019 Jul 23. Review.

18.

New insights into the mechanisms of diabetic complications: role of lipids and lipid metabolism.

Eid S, Sas KM, Abcouwer SF, Feldman EL, Gardner TW, Pennathur S, Fort PE.

Diabetologia. 2019 Sep;62(9):1539-1549. doi: 10.1007/s00125-019-4959-1. Epub 2019 Jul 25. Review.

PMID:
31346658
19.

ALS/SURV: a modification of the CAFS statistic.

Goutman SA, Brown MB, Cudkowicz M, Atassi N, Feldman EL.

Amyotroph Lateral Scler Frontotemporal Degener. 2019 Nov;20(7-8):576-583. doi: 10.1080/21678421.2019.1643375. Epub 2019 Jul 23.

PMID:
31334681
20.

Bilateral nerve conduction studies in the evaluation of distal symmetric polyneuropathy.

Dupuis JE, Li J, Callaghan BC, Reynolds EL, London ZN.

Muscle Nerve. 2019 Sep;60(3):305-307. doi: 10.1002/mus.26616. Epub 2019 Jul 2.

PMID:
31228276

Supplemental Content

Loading ...
Support Center